FDA approves tropinetide for treatment of Rett syndrome

Published Date: 16 Mar 2023

The FDA has approved tropinetide (Daybue; Acadia Pharmaceuticals) to treat Rett syndrome in patients 2 years of age and older.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Disparities in use of MRI to detect prostate cancer: Race and location may influence testing

2.

Prior authorizations draining time, energy from many cancer patients

3.

Weight loss and cancer; no brain tumor blood test; no cervical cancer after HPV vaccination.

4.

novel technique for early myelodysplastic syndrome relapse detection in blood cancer patients.

5.

The hidden costs of cancer for young survivors are derailing their financial futures


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot